Company intelligence / Profile preview

Adria Laboratories

Columbus, Ohio, United Statesadria.tm.fr ↗

Ownership: Private
Development stage: Other

Overview

Adria Laboratories was a U.S.-based pharmaceutical company with a strong focus on oncology and neurology therapeutics. It developed and marketed several drugs, including those for cancer treatment. The company was known for its research facilities in Columbus, Ohio, and had clinical involvement in studies such as the use of cabergoline for Parkinson's disease[4]. It operated as a subsidiary of Erbamont Inc., before being acquired.

Therapeutic areas: NeurologyOncology
Modalities: Small moleculeBiologic
Industry: Biotech

Beyond the preview

Go deeper on Adria Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adria Laboratories.

Explore the full profile